MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
AVROBIO ROE Ratio 2011-2026 | AVRO
Annual ROE Ratio AVROBIO
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.83 | -140.49 | -70.29 | -47.07 | -39.23 | -37.94 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.83 | -140.49 | -53.7 |
Quarterly ROE Ratio AVROBIO
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -31.22 | -35.89 | -36.47 | -4.11 | 8.49 | 32.87 | 55.43 | -19.55 | -42.97 | -78.99 | -117.63 | -67.96 | -84.81 | -78.24 | -68.74 | -42.6 | -57.06 | -54.67 | -51.8 | -36.01 | -45.22 | -39.98 | -37.28 | -27.04 | -36.53 | -36.8 | -36.77 | -24.83 | 3.01 | 40.34 | 59.89 | 38.79 | 38.79 | 10.95 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 59.89 | -117.63 | -26.61 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M |  Canada |
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | USA |
 |
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | USA |
 |
Adagene
ADAG
|
-66.16 | $ 2.81 | -3.61 % | $ 158 M |  China |
 |
Biogen
BIIB
|
9.76 | $ 176.6 | 0.24 % | $ 25.7 B | USA |
 |
BioNTech SE
BNTX
|
1.11 | $ 114.69 | -1.78 % | $ 27.2 B | Germany |
 |
ANI Pharmaceuticals
ANIP
|
-4.59 | $ 80.99 | -1.23 % | $ 1.56 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Amgen
AMGN
|
69.59 | $ 340.73 | -0.64 % | $ 183 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-40.17 | - | - | $ 1.01 B | USA |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M |  France |
 |
Burford Capital Limited
BUR
|
10.1 | $ 9.61 | -0.47 % | $ 1.53 B |  Britain |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Aytu BioScience
AYTU
|
-71.51 | $ 2.59 | 0.39 % | $ 16.3 M | USA |
 |
CASI Pharmaceuticals
CASI
|
-43.38 | $ 0.99 | -0.01 % | $ 135 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.25 | -0.35 % | $ 7.82 B |  Australia |
 |
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | USA |
 |
Catalyst Biosciences
CBIO
|
540.06 | $ 9.72 | -4.19 % | $ 640 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | USA |
 |
Cerus Corporation
CERS
|
-37.26 | $ 2.25 | -3.02 % | $ 415 M | USA |
 |
Aptose Biosciences
APTO
|
559.76 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | USA |
 |
Cellectis S.A.
CLLS
|
-26.25 | $ 3.91 | -2.03 % | $ 116 M | France |
 |
Brickell Biotech
BBI
|
-57.34 | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | USA |
 |
Beam Therapeutics
BEAM
|
-51.36 | $ 28.22 | -3.65 % | $ 2.32 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
-43.41 | $ 223.02 | -0.42 % | $ 5 B |  Danmark |
 |
Athira Pharma
ATHA
|
-216.19 | - | - | $ 269 M | USA |
 |
Atreca
BCEL
|
-123.92 | - | -11.76 % | $ 5.79 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
22.52 | $ 24.39 | -0.77 % | $ 2.89 B | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
-0.35 | $ 68.44 | -0.98 % | $ 9.15 B | USA |
 |
Cardiff Oncology
CRDF
|
-54.77 | $ 1.69 | 4.77 % | $ 80.5 M | USA |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | USA |
 |
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
-1239.35 | - | -9.72 % | $ 5.89 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-288.19 | - | -15.15 % | $ 60.3 M | Britain |
 |
Berkeley Lights
BLI
|
-69.02 | - | -7.31 % | $ 87 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-144.96 | $ 4.04 | -1.5 % | $ 8.79 B |  Israel |
 |
Amneal Pharmaceuticals
AMRX
|
67.61 | $ 13.91 | -1.45 % | $ 4.3 B | USA |
 |
AIkido Pharma
AIKI
|
-36.89 | - | 1.93 % | $ 17.4 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
-782.6 | - | -74.18 % | $ 955 K | USA |
 |
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | USA |